Aminolabs Nutrition has acquired Zoka Pharma to enhance its product offerings and strengthen its market position in the rapidly growing health and nutrition sector in Spain.

Information on the Target

Zoka Pharma, based in Valencia, has established itself as a prominent player in the health and nutrition sector, currently generating an annual revenue of €11 million with a workforce of around 50 employees. With only 30% of its production capacity utilized, Zoka Pharma offers significant potential for growth, as the company aims to double its revenue in Spain to €20 million within the next two years.

The company's robust product portfolio and advanced manufacturing infrastructure enable Aminolabs to diversify its offerings with new categories including gels, baby food, pet supplements, liquids, and probiotics. This acquisition strengthens Aminolabs' production capabilities in core forms such as tablets, capsules, and stick packs, allowing the company to respond more swiftly and flexibly to the increasing market demand.

Industry Overview in Spain

The health and nutrition industry in Spain has been experiencing rapid growth, driven by increasing consumer awareness regarding wellness and preventive healthcare. This sector is c